Androgenic alopecia. Other androgenic alopecia
Conditions
Interventions
Intervention 1: Control group: Minoxidil solution 5%, produced by Pak darou inc, 20 drops, twice a day, for 3 months and finasteride 1 mg tablet, produced by Shafa inc, 1 tablet daily for 3 months. In
Sponsors
Tabriz University of Medical Sciences
Oxin darou Vesht
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Men with androgenetic hair loss type 1 to 4
Exclusion criteria
Exclusion criteria: Having varicocele Willing to get pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of hair loss. Timepoint: Measuring hair loss at the beginning of the study (before the intervention) and 30, 60 and 90 days after the start of the medication. Method of measurement: Monthly scoring for hair loss of 10 based on patient's claim.;The hair thickness. Timepoint: Measuring the thickness of the hair at the beginning of the study (before the intervention) and 30, 60 and 90 days after the start of the medication. Method of measurement: Trichoscope.;The number of hair in a circle 2.54 cm in diameter. Timepoint: Counting the number of hair at the beginning of the study (before the intervention) and 30, 60 and 90 days after starting the medication. Method of measurement: Macrophotography technique. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSanaz Ghasempour
Tabriz University of Medical Sciences
Outcome results
None listed